BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 23407050)

  • 1. Genetic variation-optimized treatment benefit of angiotensin-converting enzyme inhibitors in patients with stable coronary artery disease: a 12-year follow-up study.
    Lee JK; Wu CK; Tsai CT; Lin LY; Lin JW; Chien KL; Hwang JJ; Lin CL; Tseng CD; Chiang FT
    Pharmacogenet Genomics; 2013 Apr; 23(4):181-9. PubMed ID: 23407050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demonstrating the pharmacogenetic effects of angiotensin-converting enzyme inhibitors on long-term prognosis of diastolic heart failure.
    Wu CK; Luo JL; Tsai CT; Huang YT; Cheng CL; Lee JK; Lin LY; Lin JW; Hwang JJ; Chiang FT
    Pharmacogenomics J; 2010 Feb; 10(1):46-53. PubMed ID: 19752885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variation in the renin-angiotensin system modifies the beneficial effects of ACE inhibitors on the risk of diabetes mellitus among hypertensives.
    Bozkurt O; Verschuren WM; van Wieren-de Wijer BM; Knol MJ; de Boer A; Grobbee DE; Geerlings MI; Heerdink ER; Klungel OH
    J Hum Hypertens; 2008 Nov; 22(11):774-80. PubMed ID: 18563171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variation in the renin-angiotensin-aldosterone system is associated with cardiovascular risk factors and early mortality in established coronary heart disease.
    Ellis KL; Palmer BR; Frampton CM; Troughton RW; Doughty RN; Whalley GA; Ellis CJ; Pilbrow AP; Skelton L; Yandle TG; Richards AM; Cameron VA
    J Hum Hypertens; 2013 Apr; 27(4):237-44. PubMed ID: 22739771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renin-Angiotensin System Genes Polymorphisms and Long-Term Prognosis in Taiwanese Patients with Hypertension and Coronary Artery Disease.
    Wu CK; Lee JK; Lin LY; Huang YT; Hwang JJ; Lin CL; Tseng CD; Chiang FT
    Acta Cardiol Sin; 2013 Jan; 29(1):28-36. PubMed ID: 27122682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polygenetic regression model of renin-angiotensin system genes and the risk of coronary artery disease in a large angiographic population.
    Tsai CT; Hwang JJ; Wu CK; Lee JK; Tseng CD; Wang YC; Hsu KL; Lai LP; Lin JL; Chiang FT
    Clin Chim Acta; 2011 Mar; 412(7-8):619-24. PubMed ID: 21184753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of genetic variation on therapy with angiotensin converting enzyme inhibitors or angiotensin receptor blockers in dialysis patients.
    Böger CA; Götz AK; Krüger B; Hösl M; Schmitz G; Riegger GA; Krämer BK
    Eur J Med Res; 2005 Apr; 10(4):161-8. PubMed ID: 15946912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renin-angiotensin system gene polymorphisms influence blood pressure and the response to angiotensin converting enzyme inhibition.
    Hingorani AD; Jia H; Stevens PA; Hopper R; Dickerson JE; Brown MJ
    J Hypertens; 1995 Dec; 13(12 Pt 2):1602-9. PubMed ID: 8903618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery disease.
    Brugts JJ; Isaacs A; Boersma E; van Duijn CM; Uitterlinden AG; Remme W; Bertrand M; Ninomiya T; Ceconi C; Chalmers J; MacMahon S; Fox K; Ferrari R; Witteman JC; Danser AH; Simoons ML; de Maat MP
    Eur Heart J; 2010 Aug; 31(15):1854-64. PubMed ID: 20538738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multilocus analysis in candidate genes ACE, AGT, and AGTR1 and predisposition to peripheral arterial disease: role of ACE D/-240T haplotype.
    Fatini C; Sticchi E; Sofi F; Said AA; Pratesi G; Pulli R; Pratesi C; Abbate R
    J Vasc Surg; 2009 Dec; 50(6):1399-404. PubMed ID: 19782519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetic interactions between angiotensin-converting enzyme inhibitor therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure.
    McNamara DM; Holubkov R; Postava L; Janosko K; MacGowan GA; Mathier M; Murali S; Feldman AM; London B
    J Am Coll Cardiol; 2004 Nov; 44(10):2019-26. PubMed ID: 15542286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renin-angiotensin system polymorphisms and the association between use of angiotensin II receptor blockers or angiotensin-converting enzyme inhibitors and the risk of diabetes.
    Bozkurt O; de Boer A; Grobbee DE; Kroon AA; Schiffers P; de Leeuw P; Klungel OH
    J Renin Angiotensin Aldosterone Syst; 2009 Jun; 10(2):101-8. PubMed ID: 19502258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haplotype-based association of ACE I/D, AT1R 1166A>C, and AGT M235T polymorphisms in renin-angiotensin-aldosterone system genes in Korean women with idiopathic recurrent spontaneous abortions.
    Choi YS; Kwon H; Kim JH; Shin JE; Choi Y; Yoon TK; Choi DH; Kim NK
    Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):225-8. PubMed ID: 21636204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of deletion in angiotensin-converting enzyme but not A1166C angiotensin II type-1 receptor gene polymorphisms to clinical outcomes in atherothrombotic disease.
    Le Hello C; Fradin S; Morello R; Coffin O; Maïza D; Hamon M
    Arch Med Res; 2011 Apr; 42(3):202-10. PubMed ID: 21722816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of renin-angiotensin system, angiotensin І converting enzyme (insertion/deletion), and angiotensin ІІ type 1 receptor (A1166C) polymorphisms on breast cancer survival in Iran.
    Namazi S; Daneshian A; Mohammadianpanah M; Jafari P; Ardeshir-Rouhani-Fard S; Nasirabadi S
    Gene; 2013 Dec; 532(1):125-31. PubMed ID: 24055489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renin-angiotensin system and haemostasis gene polymorphisms and outcome after coronary artery bypass graft surgery.
    Völzke H; Kleine V; Robinson DM; Grimm R; Hertwig S; Schwahn C; Eckel L; Rettig R
    Int J Cardiol; 2005 Jan; 98(1):133-9. PubMed ID: 15676177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between gene polymorphisms of renin-angiotensin system and metabolic risk factors in premature myocardial infarction.
    Petrovic D; Zorc M; Kanic V; Peterlin B
    Angiology; 2001 Apr; 52(4):247-52. PubMed ID: 11330506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of gene polymorphisms in the renin-angiotensin system to macroangiopathy in patients with diabetic nephropathy.
    Wong TY; Szeto CC; Chow KM; Chan JC; Li PK
    Am J Kidney Dis; 2001 Jul; 38(1):9-17. PubMed ID: 11431175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renin-angiotensin system gene polymorphisms: assessment of the risk of coronary heart disease.
    Buraczyńska M; Pijanowski Z; Spasiewicz D; Nowicka T; Sodolski T; Widomska - Czekajska T; Ksiazek A
    Kardiol Pol; 2003 Jan; 58(1):1-9. PubMed ID: 14502296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms of the renin-angiotensin system genes predict progression of subclinical coronary atherosclerosis.
    Kretowski A; McFann K; Hokanson JE; Maahs D; Kinney G; Snell-Bergeon JK; Wadwa RP; Eckel RH; Ogden L; Garg S; Li J; Cheng S; Erlich HA; Rewers M
    Diabetes; 2007 Mar; 56(3):863-71. PubMed ID: 17327458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.